Business Wire

Signifyd Opens EMEA Headquarters in London to Support Its Growing Ecommerce Fraud Protection Business in Europe

3.12.2018 11:01:00 EET | Business Wire | Press release

Share

Signifyd, the leading guaranteed fraud protection provider, today announced the opening of its EMEA headquarters in London’s West End to serve the rapid growth of its European customer base.

The company’s newest location will help Signifyd deliver its friction-free guaranteed fraud protection to merchants throughout Europe, where it is protecting more orders shipped by more retailers than ever before.

The value of European orders guaranteed by Signifyd’s innovative technology has increased by more than four times in the last two years. Its customer base in European countries has doubled, reaching more than 500 retailers of all sizes and verticals within all major European ecommerce markets.

“As we’ve accelerated our international expansion and our move into the enterprise retail sector, it’s vital that we build a team with a broad worldview and one that works in the geographies where our customers work,” said Signifyd Co-Founder and CEO Raj Ramanand. “That means we can be more responsive and that we can proactively help solve the challenges our customers face, no matter where they operate.”

Signifyd’s investment in the EMEA market has been ongoing. The company was an industry leader in adopting international standards, including the European Union’s General Data Protection Regulation and Privacy Shield. And the London office announcement comes at a time when the company is also opening its Belfast Labs, an R&D center in Northern Ireland, to support Signifyd technology and innovation globally.

Ecommerce is not a one-size-fits-all brand of business when it comes to global consumers. As Signifyd has helped retailers expand into new markets internationally, it has understood that a fraud protection solution built for one country or region can’t simply be dropped on top of the fraud threats of another.

Building a bigger presence in Europe is a natural next step for Signifyd, which analysts Frost & Sullivan recently praised for having the most diverse first-party set of transactional and behavioral data to determine whether online orders are legitimate or fraudulent.

“With over 10,000 customers in more than 100 countries Signifyd is clearly the market leader in the guaranteed fraud protection industry,” Frost & Sullivan concluded in an October research report.

Signifyd’s EMEA headquarters will be led by Ed Whitehead, a London-based sales executive who has worked for companies including EMR, Experian and Gigya.

“This is an exciting day for Signifyd, but more importantly, it’s an exciting day for online merchants operating in Europe,” said Whitehead, Signifyd’s managing director for Europe. “Guaranteed fraud protection has captured the mainstream market. But we know that retailers in different parts of the world face different challenges and have different priorities.”

Whitehead said he is thrilled with the opportunity to build a team in London that will shape the company’s EMEA strategy.

Signifyd’s Belfast Labs, located in the city’s Cathedral Quarter, is another sign of the company’s commitment to the European market. The center will house a team of top engineers driving Signifyd innovation globally, while supporting teams around the world.

Trevor McCullough, director of engineering at the Belfast Labs, said he expects the center to be on an aggressive growth path — something he looks forward to.

“The Signifyd Belfast Labs is a great opportunity for those who want to dive into machine learning and other significant technologies and craft solutions that make a real difference in the business fortunes of ecommerce retailers around the world,” McCullough said. “Not to mention the center provides a great opportunity to work with some of the best minds in technology today.”

The European expansion marks the most recent milestone in Signifyd’s torrid growth trajectory. In the last year, the company has doubled its number of customers, secured a $100 million round of funding and been named an industry leader by Deloitte, Frost & Sullivan and CBE Insights.

It is the latest sign that the guaranteed fraud protection model is the way of the future. The model combines big data, machine learning and a financial liability shift to help merchants provide a friction-free buying experience for their customers without fear of fraud.

About Signifyd

Signifyd, the world’s largest provider of guaranteed fraud protection, enables online retailers to provide a friction-free buying experience for their customers. Signifyd leverages big data, machine learning and domain expertise to virtually eliminate manual reviews, speed up order processing and increase revenue through higher approval rates. The guarantee shifts the financial liability for fraud away from retailers, allowing them to open new markets while reducing risk. Signifyd counts among its customers a number of companies on the Fortune 1000 and Internet Retailer Top 500 lists. Signifyd is headquartered in San Jose, CA, and London, with locations in Barcelona and Belfast.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Signifyd
Mike Cassidy
mike.cassidy@signifyd.com
+1-650-283-7084

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Incyte’s Pivotal frontMIND Trial Showed Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Significantly Prolonged Progression-free Survival, Reducing the Risk of Disease Progression or Death by 25% in Patients with Previously Untreated, High-risk DLBCL30.5.2026 15:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP alone as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. The oral presentation of these data is taking place at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting being held May 29 – June 2, 2026, in Chicago (Abstract #LBA7000. Session: Oral Abstract Session – Hematologic Malignancies – Lymphoma and Chronic Lymphocytic Leukemia. May 30, 4:00 – 7:00 p.m. ET [3:00 – 6:00 p.m.

Fortegra Completes Acquisition by DB Insurance29.5.2026 23:30:00 EEST | Press release

The Fortegra Group, Inc. ("Fortegra"), a global specialty insurance company, today announced the completion of its acquisition by DB Insurance Co., Ltd. ("DB"), one of Korea's leading property and casualty insurers. The transaction, announced on September 26, 2025, received all required regulatory and stockholder approvals. Fortegra will operate independently, maintaining its existing leadership team, distribution relationships, and underwriting discipline. Agents, distribution partners, and customers will continue to experience the service excellence that has defined the Fortegra experience. Richard Kahlbaugh, Chairman and CEO of Fortegra, said: "Every company eventually changes ownership. That is the nature of business. The closing of this acquisition is a starting point. As part of DB Insurance, Fortegra is positioned to expand our business geographically, enhance our capabilities and deepen our market presence in the US, Europe, the United Kingdom and Asia. Together, DB Insurance a

SINOVAC Receives Nasdaq Notification Regarding Late Filing of 2025 Annual Report29.5.2026 23:01:00 EEST | Press release

Sinovac Biotech Ltd. (Nasdaq: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received a notification letter dated May 20, 2026 (the “Notification Letter”), from Nasdaq Listing Qualifications (“Nasdaq”) stating that as of May 8, 2026, the Company had regained compliance with the periodic filing and interim financial requirements in Nasdaq Listing Rules 5250(c)(1) (the “Periodic Filing Rule”) and 5250(c)(2), as required by the Panel’s decision dated January 21, 2026. As previously disclosed on January 22, 2026, under the Panel’s decision, SINOVAC was required to, on or before May 11, 2026, demonstrate compliance with such Nasdaq Listing Rules by completing filings of its annual report for the year ended December 31, 2024, on Form 20-F and an interim balance sheet and income statement as of the end of its second quarter of 2025 on Form 6-K. The Company timely completed such filings as required by the Panel’s decision.

From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 16:00:00 EEST | Press release

NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under 20 minutes, saving hundreds of hours of engineer time, shrinking MTTR by more than 95%. A global telecommunications firm found NetBrain's context-grounded agents outperformed a stand-alone frontier LLM on a persistent firewall

Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 15:00:00 EEST | Press release

Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consistent approach to protecting our innovation and our customers,” said Justin Ferguson, SVP and general counsel at Adtran. “We take all claims seriously, but we will not hesitate to defend ourselves when assertions lack merit. Situations like this place unnecessary strain on technology providers and divert resources from advancing networks and services. By advancing our counterclaim

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye